Prurigo-oriented web-survey regarding treatment and quality of life in Japa
Not Applicable
- Conditions
- chronic prurigo
- Registration Number
- JPRN-UMIN000047643
- Lead Sponsor
- Sanofi K.K.
- Brief Summary
Thise analysis was performed for 130 dermatologists who see prurigo nodularis (PN) and 97 patients diagnosed with prurigo nodularis by these physicians. The disease burden of patients with PN increased with severity, and satisfaction with treatment was lower with severity. Topical steroids and antihistamines are more common treatment. Variety of drugs were used with increasing severity, but treatment satisfaction was not improved.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 359
Inclusion Criteria
Not provided
Exclusion Criteria
-Applicable to inappropriate responses
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Correlation between demographic characteristics and the following scores -Correlation between treatment for prurigo nodularis and the following scores (GQ/NRS/DLQI/SF-8/WPAI/PHQ-9 scores)
- Secondary Outcome Measures
Name Time Method -Correlation between treatment satisfaction for prurigo nodularis and demographic characteristics -Correlation between treatment satisfaction for prurigo nodularis and the following each score (GQ/NRS/DLQI/SF-8/WPAI/PHQ-9 scores)